Sonoma Pharmaceuticals Highlights Safety Advantages Of Microcyn Products
Author: Benzinga Newsdesk | March 27, 2024 07:37am
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care and dermatological conditions, highlights the safety advantages of its Microcyn technology products in response to concerns related to benzoyl peroxide, a common ingredient in dermatology products.
Posted In: SNOA